Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Press Releases

Phase 1 clinical trial of HIV vaccine starts in Africa to evaluate immune responses to highly networked HIV T-cell epitopes

August 4, 2025

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Read more

Videos

Delivering vaccines during an Ebola outbreak

August 1, 2025

Discover how IAVI and our partners collaborated to accelerate the response to Uganda’s sixth outbreak of Sudan virus disease, including the launch of a ring vaccination trial just four days after the outbreak was announced. Sudan virus (SUDV) is an orthoebolavirus that causes a severe and often fatal viral hemorrhagic fever. We sat down with Swati Gupta, IAVI’s VP and head of emerging infectious diseases and epidemiology, to discuss this blueprint for a successful outbreak response. Watch this IAVI Impact video to learn about the global health security risks posed by SUDV, and how a vaccine is urgently needed to help prevent future outbreaks.

Read more

Features

IAVI announces first enrollment in tuberculosis epidemiology study

July 31, 2025

This study supports the preparation for late-stage tuberculosis (TB) vaccine efficacy trials by providing key epidemiological data.

Read more

Features

IAS 2025 Kigali reaffirms what it will take to keep HIV progress from sliding back

July 25, 2025

Science and equity must move together, supported by sustained funding, to keep the HIV response on track.

Read more

In The News

Non-profits wade in where for-profit life science investment fears to tread

Nature Biotechnology

July 22, 2025

Read more

In The News

The HIV Prevention Pipeline | IAS 2025

Managed Healthcare Executive

July 15, 2025

Read more

In The News

Research Roundup: Sudan virus vaccine funding

Global Health Technologies Coalition

July 14, 2025

Read more

Features

IAVI receives €1 million from Dutch government for Sudan virus vaccine development

July 10, 2025

Grant supports ongoing clinical efficacy trial in Uganda in response to Sudan virus disease outbreak.

Read more